Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 684

1.

High Prevalence of Atrial Fibrillation Among Patients With Ischemic Stroke.

Friberg L, Rosenqvist M, Lindgren A, Terént A, Norrving B, Asplund K.

Stroke. 2014 Jul 17. pii: STROKEAHA.114.006070. [Epub ahead of print]

PMID:
25034713
[PubMed - as supplied by publisher]
2.

Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis.

AbuDagga A, Stephenson JJ, Fu AC, Kwong WJ, Tan H, Weintraub WS.

BMC Health Serv Res. 2014 Jul 17;14(1):310. [Epub ahead of print]

PMID:
25034699
[PubMed - as supplied by publisher]
Free Article
3.

Anticoagulation: choosing the optimal anticoagulant.

Hawes EM, Viera AJ.

FP Essent. 2014 Jul;422:18-23.

PMID:
25033002
[PubMed - in process]
4.

Anticoagulation-related reduction of first-ever stroke severity in Chinese patients with atrial fibrillation.

Wang C, Wang Y, Wang C, Zhao X, Liu L, Liu G, Wang DZ, Li H, Wang Y.

J Clin Neurosci. 2014 Jul 3. pii: S0967-5868(14)00190-8. doi: 10.1016/j.jocn.2014.01.022. [Epub ahead of print]

PMID:
24998862
[PubMed - as supplied by publisher]
5.

Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy: The PREVAIL Trial.

Holmes DR Jr, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, Huber K, Reddy VY.

J Am Coll Cardiol. 2014 Jul 8;64(1):1-12. doi: 10.1016/j.jacc.2014.04.029.

PMID:
24998121
[PubMed - in process]
6.

Meta-Analysis of Efficacy and Safety of Rivaroxaban Compared With Warfarin or Dabigatran in Patients Undergoing Catheter Ablation for Atrial Fibrillation.

Aryal MR, Ukaigwe A, Pandit A, Karmacharya P, Pradhan R, Mainali NR, Pathak R, Jalota L, Bhandari Y, Donato A.

Am J Cardiol. 2014 Jun 6. pii: S0002-9149(14)01231-4. doi: 10.1016/j.amjcard.2014.05.038. [Epub ahead of print]

PMID:
24998087
[PubMed - as supplied by publisher]
7.

Inappropriate Use of Oral Anticoagulants for Patients With Atrial Fibrillation.

Akao M, Chun YH, Esato M, Abe M, Tsuji H, Wada H, Hasegawa K.

Circ J. 2014 Jun 27. [Epub ahead of print]

PMID:
24976391
[PubMed - as supplied by publisher]
Free Article
8.

Cost-effectiveness of dabigatran versus vitamin K antagonists for the prevention of stroke in patients with atrial fibrillation: A French payer perspective.

Chevalier J, Delaitre O, Hammès F, de Pouvourville G.

Arch Cardiovasc Dis. 2014 Jun 24. pii: S1875-2136(14)00103-X. doi: 10.1016/j.acvd.2014.04.009. [Epub ahead of print]

PMID:
24973113
[PubMed - as supplied by publisher]
9.

Dabigatran etexilate in atrial fibrillation.

Vora A.

J Assoc Physicians India. 2013 Dec;61(12):900-2.

PMID:
24968547
[PubMed - in process]
10.

[Current management of antithrombotic treatment in patients with non valvular atrial fibrillation and prior history of stroke or transient ischemic attack].

Masjuan J, Alvarez-Sabin J, Blanco M, de Felipe A, Gil-Nunez A, Gallego-Cullere J, Vivancos J.

Rev Neurol. 2014 Jul 1;59(1):25-36. Spanish.

PMID:
24965928
[PubMed - in process]
Free Article
11.

Edoxaban in the evolving scenario of non vitamin k antagonist oral anticoagulants imputed placebo analysis and multiple treatment comparisons.

Verdecchia P, Angeli F, Lip GY, Reboldi G.

PLoS One. 2014 Jun 23;9(6):e100478. doi: 10.1371/journal.pone.0100478. eCollection 2014.

PMID:
24955573
[PubMed - in process]
Free PMC Article
12.

New oral anticoagulants may be particularly useful for asian stroke patients.

Bang OY, Hong KS, Heo JH, Koo J, Kwon SU, Yu KH, Bae HJ, Lee BC, Yoon BW, Kim JS.

J Stroke. 2014 May;16(2):73-80. doi: 10.5853/jos.2014.16.2.73. Epub 2014 May 30. Review.

PMID:
24949312
[PubMed]
Free PMC Article
13.

Cerebrovascular Events in 21 105 Patients With Atrial Fibrillation Randomized to Edoxaban Versus Warfarin: Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48.

Giugliano RP, Ruff CT, Rost NS, Silverman S, Wiviott SD, Lowe C, Deenadayalu N, Murphy SA, Grip LT, Betcher JM, Duggal A, Dave J, Shi M, Mercuri M, Antman EM, Braunwald E; on behalf of the ENGAGE AF-TIMI 48 Investigators.

Stroke. 2014 Jun 19. pii: STROKEAHA.114.006025. [Epub ahead of print]

PMID:
24947287
[PubMed - as supplied by publisher]
14.

Benefits and Risks of Anticoagulation Resumption Following Traumatic Brain Injury.

Albrecht JS, Liu X, Baumgarten M, Langenberg P, Rattinger GB, Smith GS, Gambert SR, Gottlieb SS, Zuckerman IH.

JAMA Intern Med. 2014 Jun 10. doi: 10.1001/jamainternmed.2014.2534. [Epub ahead of print]

PMID:
24915005
[PubMed - as supplied by publisher]
15.

Twice- or once-daily dosing of novel oral anticoagulants for stroke prevention: a fixed-effects meta-analysis with predefined heterogeneity quality criteria.

Clemens A, Noack H, Brueckmann M, Lip GY.

PLoS One. 2014 Jun 9;9(6):e99276. doi: 10.1371/journal.pone.0099276. eCollection 2014.

PMID:
24911432
[PubMed - in process]
Free PMC Article
16.

Management and 1-Year Outcomes of Patients With Atrial Fibrillation in the Middle East: Gulf Survey of Atrial Fibrillation Events.

Zubaid M, Rashed WA, Alsheikh-Ali AA, Al-Zakwani I, AlMahmeed W, Shehab A, Sulaiman K, Qudaimi AA, Asaad N, Amin H; on behalf of the Gulf Survey of Atrial Fibrillation Events (Gulf SAFE) Investigators.

Angiology. 2014 Jun 5. pii: 0003319714536980. [Epub ahead of print]

PMID:
24904179
[PubMed - as supplied by publisher]
17.

Atrial fibrillation, stroke, and anticoagulation in medicare beneficiaries: trends by age, sex, and race, 1992-2010.

Shroff GR, Solid CA, Herzog CA.

J Am Heart Assoc. 2014 Jun 3;3(3):e000756. doi: 10.1161/JAHA.113.000756.

PMID:
24895161
[PubMed - in process]
Free Article
18.

Stroke prevention in atrial fibrillation: established oral anticoagulants versus novel anticoagulants-translating clinical trial data into practice.

Ezekowitz MD, Spahr J, Ghosh P, Corelli K.

J Interv Card Electrophysiol. 2014 Jun 1. [Epub ahead of print]

PMID:
24880227
[PubMed - as supplied by publisher]
19.

Meta-Analysis of efficacy and safety of the new anticoagulants versus Warfarin in patients with Atrial Fibrillation.

Jia B, Lynn HS, Rong F, Zhang W.

J Cardiovasc Pharmacol. 2014 May 27. [Epub ahead of print]

PMID:
24869601
[PubMed - as supplied by publisher]
20.

Presentation, therapy and outcome of patients with ischemic stroke under new oral anticoagulants.

Stöllberger C, Finsterer J.

Neurol Neurochir Pol. 2014;48(2):136-40. doi: 10.1016/j.pjnns.2014.03.001. Epub 2014 Apr 14.

PMID:
24821640
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk